 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
Parenteral iron therapy is indicated in patients with iron-deficiency anemia associated with conditions that interfere with the ingestion or absorption of oral iron. Replacement doses of iron required to replenish iron stores are based on body weight and the observed hemoglobin value. Methods of administering iron dextran are reviewed, including intramuscular and intravenous injections of the undiluted drug, intravenous infusion of a diluted preparation, and as an addition to parenteral nutrition solutions. The overall incidence of adverse reactions associated with the parenteral administration of iron is low, but the potential for an anaphylactic reaction requires that an initial test dose be given followed by careful patient observation.
This article has been cited by other articles:
|
|
 |
|
  G. C. Wall and R. A. Pauly Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia Am. J. Health Syst. Pharm., January 15, 2008; 65(2): 150 - 153. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
